Low-grade systemic inflammation and the response to exercise training in patients with advanced COPD

Chest

Volumn 128, Issue 5, 2005, Pages 3183-3190

  Spruit, Martijn A ^a   Gosselink, Rik ^b   Troosters, Thierry ^a   Kasran, Ahmad ^b   Van Vliet, Monique ^a   Decramer, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

COPD; Exercise training; Gender differences; Interleukin 8; Physiotherapy; Skeletal muscle strength; Soluble tumor necrosis factor receptor; Systemic inflammation; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 8; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR P55; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BELGIUM; CATABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY DISEASE QUESTIONNAIRE; CONTROLLED STUDY; DISEASE MARKER; ENDURANCE; EXERCISE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE FORCE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WALKING;

EID: 28144447731     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3183     Document Type: Article

References (45)

1. Spruit MA, Troosters T, Trappenburg JCA, et al. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Conns 2004; 52:243-248
2. Ambrosino N, Strambi S. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 2004; 24:313-322
3. O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004; 126:903-914
4. Puhan MA, Schunemann HJ, Frey M, et al. How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax 2005; 60:367-375
5. Troosters T, Gosselink R, Decramer M. Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil 2001; 21:10-17
6. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-580
7. Creutzberg EC, Schols AM, Weling-Scheepers CA, et al. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:745-752
8. Bruunsgaard H, Bjerregaard E, Schroll M, et al. Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old. J Am Geriatr Soc 2004; 52:237-241
9. Fernandez-Celemin L, Pasko N, Blomart V, et al. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α. Am J Physiol Endocrinol Metab 2002; 283:E1279-E1290
10. Adams GR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev 1998; 26:31-60
11. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59:387-395
12. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58:752-756
13. Spruit MA, Gosselink R, Troosters T, et al. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002; 19:1072-1078
14. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60:32-38
15. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal; official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40
16. Decramer M, Lacquet LM, Fagard R, et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994; 150:11-16
17. Jones NL, Makrides L, Hitchcock C, et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131:700-708
18. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-822
19. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14:270-274
20. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773-778
21. Borg GAV. Borg's perceived exertion and pain scales. 1st ed. Champaign, IL: Human Kinetics, 1998; 1-112
22. Mejia R, Ward J, Lentine T, et al. Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. Am J Respir Crit Care Med 1999; 159:1485-1489
23. Altman DG, Gore SM, Gardner MJ, et al. Statistical guidelines for contributors to medical journals. BMJ (Clin Res Ed) 1983; 286:1489-1493
24. Couser JI Jr, Guthmann R, Hamadeh MA, et al. Pulmonary rehabilitation improves exercise capacity in older elderly patients with COPD. Chest 1995; 107:730-734
25. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:555-561
26. 2. Am Rev Respir Dis 1988; 138:1519-1523
27. Zu Wallack RL, Patel K, Reardon JZ, et al. Predictors of improvement in the 12-minute walking distance following a six-week outpatient pulmonary rehabilitation program. Chest 1991; 99:805-808
28. American College of Sports Medicine. American College of Sports Medicine position stand: exercise and physical activity for older adults. Med Sci Sports Exerc 1998; 30:992-1008
29. Bigda J, Holtmann H. TNF receptors-how they function and interact. Arch Immunol Ther Exp (Warsz) 1997; 45:263-270
30. Hale KK, Smith CG, Baker SL, et al. Multifunctional regulation of the biological effects of TNF-α by the soluble type I and type II TNF receptors. Cytokine 1995; 7:26-38
31. Bemelmans MH, Gouma DJ, Buurman WA. LPS-induced sTNF-receptor release in vivo in a murine model: investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-γ. J Immunol 1993; 151:5554-5562
32. Grounds MD, Torrisi J. Anti-TNF α (Remicade) therapy-protects dystrophic skeletal muscle from necrosis. FASEB J 2004; 18:676-682
33. Toussirot E, Wendling D. The use of TNF-α blocking agents in rheumatoid arthritis: an overview. Expert Opin Pharmacother 2004; 5:581-594
34. Wendling D, Toussirot E. Anti-TNF-α therapy in ankylosing spondylitis. Expert Opin Pharmacother 2004; 5:1497-1507
35. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:972-977
36. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:870-878
37. Ringbaek T, Seersholm N, Viskum K. Standardised mortality rates in females and males with COPD and asthma. Eur Respir J 2005; 25:891-895
38. Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98:1207-1213
39. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150:1453-1455
40. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:395-399
41. Bouchard C, An P, Rice T, et al. Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study. J Appl Physiol 1999; 87:1003-1008
42. Frederiksen H, Bathum L, Worm C, et al ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin Exp Res 2003; 15:284-291
43. Thomis MA, Huygens W, Heuninckx S, et al. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme, insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol 2004; 92:267-274
44. Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 2000; 85:575-579
45. Gosker HR, Pennings HJ, Schols AM. ACE gene polymorphism in COPD. Am J Respir Crit Care Med 2004; 170:572-573